Global Psoriasis Therapeutics Market Forecast Report 2015-2019

Global Psoriasis Therapeutics Market 2015-2019 is the latest addition to industry research reports collection.

Psoriasis is a common immune-mediated disease of the skin. In psoriasis, the skin grows fast and causes buildup of thick white, red, or silvery patches of skin. It alters the normal cell cycle of the skin. The new cells of the skin grow and move quickly to the surface of the skin to form patches known as “plaques”. The plaques are commonly found on knees, elbows, scalp, hands, and feet. Psoriasis occurs mostly in adults, but can also be seen in children and adolescents. The etiology of the disease is unknown, however, it is believed to be an immune-mediated process. It is believed that the over-activity of the immune system can cause inflammation, thereby resulting in flaking of the skin.

Analysts forecast the Global Psoriasis Therapeutics market to grow at a CAGR of 9.95 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Psoriasis Therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs including systemic and topical drugs used in the treatment of:

  • Psoriasis
  • Psoriatic Arthritis

The Global Psoriasis Therapeutics market is segmented based on the mechanism of action of the drugs used to treat psoriasis and psoriatic arthritis as illustrated below:

  • TNF Inhibitors
  • PDE4 Inhibitors
  • Interleukin Blockers
  • Others

The Global Psoriasis Therapeutics market is also segmented based on the type of molecule used for the treatment of psoriasis, as illustrated below:

  • Biologics
  • Small Molecules

On the basis of route of administration adopted for the treatment of psoriasis, the Global Psoriasis Therapeutics market is segmented as follows:

  • Oral
  • Parenteral
  • Topical

Order a copy of this report at (Prices start at US $3000 for a single user PDF) .

The report also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the Global Psoriasis Therapeutics market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. In addition, late-stage pipeline molecules developed for the treatment of psoriasis have been discussed.

Global Psoriasis Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC and the EMEA regions; it also covers the Global Psoriasis Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbvie
  • Amgen
  • Janssen Pharmaceuticals
  • Pfizer

Other Prominent Vendors

  • AbGenomics
  • Almirall
  • Anacor Pharmaceuticals
  • ApoPharma
  • Astellas Pharma
  • AstraZeneca
  • Aurinia Pharmaceuticals
  • Biocon
  • Biogen Idec
  • Biotest
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Can-Fite BioPharma
  • Celgene
  • Coherus Biosciences
  • Creabilis
  • Dermira
  • Eli Lilly
  • F. Hofffmann-La Roche
  • Forward Pharma
  • G & W Laboratories
  • GlaxoSmithKline
  • Idera Pharmaceuticals
  • Kadmon
  • Kyowa Hakko Kirin
  • LEO Pharma
  • Maruho
  • Merck
  • Moleculin
  • MorphoSys
  • Novartis
  • Pfizer
  • Promius Pharma
  • Provectus Biopharmaceuticals
  • Sandoz
  • Sun Pharmaceuticals
  • Takeda Pharmaceutical
  • Taro Pharmaceuticals
  • Therapeutics Inc.
  • UCB
  • Valeant Pharmaceuticals
  • VBL Therapeutics

Market Driver

  • Growing Unmet Needs

Market Challenge

  • Unknown Disease Etiology

Market Trend

  • Market Dominance by Biologics

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Have any Query on the Report get your Queries Resolved at .

End of Year Discounts: A discount of 20% on all reports by Infiniti Research Limited, published until the 24th of September 2014. Discount available till 15th January 2015.

About US: ( is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.